Physician profile
Gregory Bell
NPI 1740267525
$24,565.89
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,169 · 2020: $196 · 2022: $13K · 2023: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Travel and Lodging: $2,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Travel and Lodging | $2,150.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $23,170.34 | 2022-2023 | |
| Esaote North America, INC. | $852.60 | 2019 | |
| Endocare, INC. | $109.31 | 2019 | |
| Boston Scientific Corporation | $95.97 | 2019-2022 | |
| Foundation Medicine, INC. | $83.13 | 2020 | |
| Siemens Medical Solutions USA, INC. | $65.93 | 2019-2020 | |
| Heron Therapeutics, INC. | $31.90 | 2019 | |
| Ge Healthcare | $29.27 | 2020 | |
| Abbvie INC. | $28.64 | 2019 | |
| Medtronic USA, INC. | $27.67 | 2019-2020 | |
| Seagen INC. | $26.81 | 2020 | |
| Valeritas, INC. | $16.10 | 2019 | |
| Radius Health, INC. | $14.55 | 2019 | |
| Ibsa Pharma INC. | $13.67 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.